U.S. flag

An official website of the United States government

NM_000306.4(POU1F1):c.515G>A (p.Arg172Gln) AND Pituitary hormone deficiency, combined, 1

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
May 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000014584.28

Allele description [Variation Report for NM_000306.4(POU1F1):c.515G>A (p.Arg172Gln)]

NM_000306.4(POU1F1):c.515G>A (p.Arg172Gln)

Gene:
POU1F1:POU class 1 homeobox 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p11.2
Genomic location:
Preferred name:
NM_000306.4(POU1F1):c.515G>A (p.Arg172Gln)
HGVS:
  • NC_000003.12:g.87262160C>T
  • NG_008225.2:g.19428G>A
  • NM_000306.4:c.515G>AMANE SELECT
  • NM_001122757.3:c.593G>A
  • NP_000297.1:p.Arg172Gln
  • NP_001116229.1:p.Arg198Gln
  • NC_000003.11:g.87311310C>T
  • NM_000306.2:c.515G>A
  • NM_000306.3:c.515G>A
Protein change:
R172Q; ARG172GLN
Links:
OMIM: 173110.0013; dbSNP: rs104893765
NCBI 1000 Genomes Browser:
rs104893765
Molecular consequence:
  • NM_000306.4:c.515G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001122757.3:c.593G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Pituitary hormone deficiency, combined, 1 (CPHD1)
Synonyms:
Pituitary hormone deficiency, combined or isolated, 1
Identifiers:
MONDO: MONDO:0024464; MedGen: C2751608; OMIM: 613038

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034838OMIM
no assertion criteria provided
Pathogenic
(Aug 1, 2005)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV0025211513billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 22, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes1not providednot provided1not providedclinical testing

Citations

PubMed

Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency.

Turton JP, Reynaud R, Mehta A, Torpiano J, Saveanu A, Woods KS, Tiulpakov A, Zdravkovic V, Hamilton J, Attard-Montalto S, Parascandalo R, Vella C, Clayton PE, Shalet S, Barton J, Brue T, Dattani MT.

J Clin Endocrinol Metab. 2005 Aug;90(8):4762-70. Epub 2005 May 31.

PubMed [citation]
PMID:
15928241

Joint laxity in homozygotes for severe POU1F1 mutations.

Shamseldin HE, Maddirevula S, Nabil A, Al-Fadhil S, Al Tala S, Alkuraya FS.

Am J Med Genet A. 2016 Dec;170(12):3356-3358. doi: 10.1002/ajmg.a.37941. Epub 2016 Aug 19. No abstract available.

PubMed [citation]
PMID:
27541381
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000034838.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 Maltese sibs with combined pituitary hormone deficiency (CPHD1; 613038), Turton et al. (2005) identified a novel 515G-A transition within exon 4 of the POU1F1 gene that resulted in substitution of arginine by glutamine at codon 172 in the POU-S (R172Q). These patients were compound heterozygous for this mutation and E230K (172110.0012). Functional studies revealed that the R172Q mutation is associated with a reduction in DNA binding and transactivation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV002521151.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (3)

Description

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.84; 3Cnet: 0.80). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with POU1F1 related disorder (ClinVar ID: VCV000013614 / PMID: 15928241). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID: 15928241). The variant has been reported to co-segregate with the disease in at least 3 similarly affected relatives/individuals in the same family or similarly affected unrelated family (PMID:15928241, 27541381). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Sep 3, 2023